首页 | 本学科首页   官方微博 | 高级检索  
检索        

中医药治疗肿瘤的临床疗效评价标准探析
引用本文:邱敏,应坚,刘莉,程俊,张琼,刘勇.中医药治疗肿瘤的临床疗效评价标准探析[J].上海中医药杂志,2012(9):7-10.
作者姓名:邱敏  应坚  刘莉  程俊  张琼  刘勇
作者单位:重庆市中医院肿瘤科;重庆医科大学中医药学院
基金项目:国家中医药管理局中医药标准化专项项目(ZYYS-2010)
摘    要:通过分析当前国际肿瘤学界肿瘤治疗疗效评价方法及中医药治疗肿瘤临床疗效特点,对制定既充分体现中医疗效特点又为国内外肿瘤学界广泛接受、理解、认同的中医肿瘤临床疗效评价标准进行探讨。认为应借鉴循证医学的研究方法,以"总生存期"、"无进展生存期"或"无病生存期"等生存获益时间为主要终点指标,以临床获益率为次要终点指标,并结合对生存质量的评价,制定出既符合中医肿瘤临床疗效特点又与国际接轨的肿瘤疗效评价标准,以推动中医肿瘤学标准化、客观化、国际化进程。

关 键 词:肿瘤  中医药疗法  疗效评价  标准

Evaluation criterion of clinical efficacy for tumor treatment by Chinese medicine
QIU Min,YING Jian,LIU Li,CHENG Jun,ZHANG Qiong,LIU Yong.Evaluation criterion of clinical efficacy for tumor treatment by Chinese medicine[J].Shanghai Journal of Traditional Chinese Medicine,2012(9):7-10.
Authors:QIU Min  YING Jian  LIU Li  CHENG Jun  ZHANG Qiong  LIU Yong
Institution:1.Chongqing Municipal Hospital of Traditional Chinese Medicine;2.Chongqing Medical University
Abstract:This paper analyzes international evaluation methods and efficacy of Chinese medicine for tumor,and discusses the evaluation of clinical efficacy of Chinese medicine tumor standard,which reflects the characteristics of Chinese medicine and accepts by experts in this field at home and abroad.This paper views that evidence-based medicine should be used for the research;"overall survival","progression-free survival" or "disease-free survival" should be used as the main endpoint criteria,and clinical benefit rate should be used as secondary endpoint criteria.Combined with evaluation of quality of life,the evaluation criterion of clinical efficacy for tumor treatment by Chinese medicine was established.This evaluation criterion accords with characteristics of clinical efficacy in TCM and relates with international standards,and promotes the progress of standardization,objectification and internationalization.
Keywords:tumor  Chinese medicine  efficacy evaluation  criterion
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号